Grow Group has announced the completion of a recapitalisation, has appointed Co-CEOs, and now expects to generate healthy EBITDA in 2027.
German patients challenging the recent controversial changes to medical cannabis reimbursement via statutory health insurance (GKV) are facing lengthy battles across the country’s courts.
Medical cannabis’s cultivar names have, over the past two years, become an increasingly controversial part of the European prescription framework.
Dr. Julian Wichmann, MD, Co-Founder and CEO of Bloomwell GmbH Germany has, without question, the most progressive regulation of medical cannabis in the EU.
UK medical cannabis patients have been told that they’ll have access to a six-month stockpile of Bedrolite, following weeks of uncertainty in the wake of Bedrocan’s collapse.
UK medical cannabis cultivator Glass Pharms has partnered with leading clinic Releaf to bring cannabis containing meaningful levels of THCV (Tetrahydrocannabivarin), a cannabinoid linked to reduced appetite in emerging research, to patients in the UK for the first time since 1973.
Spain’s medical cannabis framework will finally start reaching patients over the coming days and weeks, marking a significant milestone in a four-year battle for access.
Over the last decade, the European medical cannabis landscape has seen a significant surge of new products entering the market, providing patients, especially in the UK and Germany, with a greater variety than ever before.
Frances’ incoming medical cannabis framework is expected to take the final step before it can be signed into law in the ‘coming weeks’.
